Literature DB >> 33902533

Urinary pentosidine level is associated with grip strength and gait speed in community-dwelling adults: a cross-sectional study.

Kenta Moriwaki1,2, Hiromi Matsumoto3, Chika Tanimura4, Mari Osaki5, Hideki Nagashima6, Hiroshi Hagino4,5.   

Abstract

BACKGROUND: Muscle and bone interactions might be associated with osteoporosis and sarcopenia. Urinary pentosidine and serum 25-hydroxyvitamin D (25(OH)D) might affect muscle and bone interactions. It is unclear whether these biomarkers are affected by age and sex or play a role in muscle and physical functions. We aimed to investigate the association between urinary pentosidine and serum 25(OH)D levels with muscle mass, muscle strength, and physical performance in community-dwelling adults.
METHODS: Two-hundred and fifty-four middle-aged and elderly adults were enrolled. There was no significant difference in age between 97 men (75.0 ± 8.9 years) and 157 women (73.6 ± 8.1 years). The skeletal muscle mass index (SMI), grip strength, and gait speed were assessed. The urinary pentosidine level was measured. We evaluated the association of urinary pentosidine and serum 25(OH)D levels with age and sex (student's t-test) and correlations between biomarker and each variable (Pearson's correlation coefficients). Multiple regression analysis was performed with grip strength and gait speed as dependent variables and with age, height, weight, body mass index (BMI), speed of sound (SOS), SMI, glycated hemoglobin (HbA1c), estimated glomerular filtration rate (eGFR), 25(OH)D, and pentosidine as independent variables using the stepwise method.
RESULTS: The urinary pentosidine level was negatively correlated with grip strength, gait speed, eGFR, and insulin-like growth factor-1 (IGF-1) in men and with SOS, grip strength, and gait speed in women. The serum 25(OH)D level was positively correlated with IGF-1 in women and grip strength in men. Grip strength was associated with age, height, and pentosidine in men and height and pentosidine in women. Gait speed was associated with age, BMI, and pentosidine in men and age, height, and pentosidine in women.
CONCLUSION: Urinary pentosidine levels are significantly associated with grip strength and gait speed and may serve as a biomarker of muscle and bone interactions.

Entities:  

Keywords:  25-hydroxyvitamin D; Biomarker; Estimated glomerular filtration rate; Insulin-like growth factor-1; Muscle and bone interactions; Osteoporosis; Physical function; Sarcopenia; Skeletal muscle mass index; Speed of sound

Year:  2021        PMID: 33902533     DOI: 10.1186/s12891-021-04279-5

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  1 in total

1.  Elevated Serum Pentosidine and Decreased Serum IGF-I Levels are Associated with Loss of Muscle Mass in Postmenopausal Women with Type 2 Diabetes Mellitus.

Authors:  K Tanaka; I Kanazawa; T Sugimoto
Journal:  Exp Clin Endocrinol Diabetes       Date:  2015-11-17       Impact factor: 2.949

  1 in total
  3 in total

1.  The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson's disease.

Authors:  Shusaku Omoto; Mitsuru Saito; Hidetomo Murakami; Tomotaka Shiraishi; Tomomichi Kitagawa; Takeo Sato; Hiroki Takatsu; Teppei Komatsu; Kenichiro Sakai; Tadashi Umehara; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Sci       Date:  2022-08-12       Impact factor: 3.830

2.  Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus.

Authors:  Tsung-Hui Wu; Shiow-Chwen Tsai; Hsuan-Wei Lin; Chiao-Nan Chen; Chii-Min Hwu
Journal:  BMC Endocr Disord       Date:  2022-05-04       Impact factor: 3.263

3.  Correlation between Glycation-Related Biomarkers and Quality of Life in the General Japanese Population: The Iwaki Cross-Sectional Research Study.

Authors:  Masaya Tsubokawa; Miyuki Nishimura; Koichi Murashita; Takuro Iwane; Yoshinori Tamada
Journal:  Int J Environ Res Public Health       Date:  2022-07-31       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.